Costa Rica caps prices on 68 drug ingredients to curb costs

The Costa Rican government, under President Laura Fernández, has decreed temporary price regulation on 68 active pharmaceutical ingredients, setting maximum payable prices. The measure aims to control rising medicine costs, though its impact on supply and market dynamics remains uncertain. This is a notable state intervention in the pharmaceutical market, potentially affecting drug affordability and availability.